You do know RAP is only 5 months into commercialisation and only 1 month ResAppDx was made available for Android but maybe chronic respiratory management for COPD and asthma will be the primary product as a DTC and what big pharmacy want after respiratory diagnosis and OSA.
RAP media thread., page-1663
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #